Abstract
Introduction: Multi-drug resistant organisms (MDRO) often instigate severe adverse complications and are increasingly challenging to treat in the neonatal intensive care unit (NICU). Between January–February 2017, a discernible increase in isolation of MDRO, especially of MDR Acinetobacter baumanii (MDR-AB) were noted from clinical and screening samples of infants in a 25-bed level III tertiary NICU.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
